Resource Library
Showing 81 to 90 of 330 results
Image
Dr. Kareem Jamani talks to us about CML treatment options and diagnosis.
Image
Participants will also learn about today’s treatment landscape, including first-line therapies and emerging drug classes that are shaping the future of myeloma care.
Image
When treatment for blood cancer ends, test results may show that the disease is in remission. But for many people, uncertainty lingers: Is it really gone? Could it come back? The uncertainty is understandable. Tiny numbers of cancer cells – too small for standard tests to detect – can sometimes remain in the body. Finding these hidden cells is one of the…
Image
We know more than ever about how blood cancers develop and respond to treatment. Genetic testing gives doctors better insight into what’s going on and guide treatment decision. Still, many big questions remain, including how to spot cancers earlier and who might be at higher risk.
Image
You or your loved one has been diagnosed with anaplastic large cell lymphoma (ALCL). What does it mean and how will it affect you?
Image
This insightful 90-minute webcast explores the evolving landscape of CAR T-cell therapy in Canada. Whatever your blood cancer experience, or if you are a healthcare professional, this webcast will equip you with valuable knowledge to better understand and navigate the CAR-T experience in Canada.
Image
This booklet provides a closer look at acute lymphoblastic leukemia in children, the treatments available, and the side-effects your child may experience.
Image
This fact sheet will help you:
Learn about SLL and how it is diagnosed
Get an overview of treatment options
Understand what happens next
Learn about SLL and how it is diagnosed
Get an overview of treatment options
Understand what happens next
Image
Mastocytosis is a rare blood cancer where too many mast cells (white blood cells that help fight infection) build up in the body’s tissues and organs. There are 2 types: Cutaneous (skin) mastocytosis, and systemic mastocytosis, affecting internal areas such as live, spleen and GI tract.
Image
Four LLSC-funded researchers discussing their ongoing projects looking at quality of life for people impacted by a blood cancer, moderated by LLSC Research Program Director Dr. Paul O'Connell.
This is the opening session of the 2025 Living Well with a Blood Cancer virtual conference.
This is the opening session of the 2025 Living Well with a Blood Cancer virtual conference.